Literature DB >> 10322498

Gamma-hydroxybutyric acid: an endogenous neuromodulator with abuse potential?

R Bernasconi1, P Mathivet, S Bischoff, C Marescaux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10322498     DOI： 10.1016/s0165-6147(99)01341-3

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  16 in total

1.  Modulation of absence seizures by the GABA(A) receptor: a critical rolefor metabotropic glutamate receptor 4 (mGluR4).

Authors:  O C Snead; P K Banerjee; M Burnham; D Hampson
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

Review 2.  Succinic semialdehyde dehydrogenase: biochemical-molecular-clinical disease mechanisms, redox regulation, and functional significance.

Authors:  Kyung-Jin Kim; Phillip L Pearl; Kimmo Jensen; O Carter Snead; Patrizia Malaspina; Cornelis Jakobs; K Michael Gibson
Journal:  Antioxid Redox Signal       Date:  2011-04-10       Impact factor: 8.401

Review 3.  Drugs for sleep disorders: mechanisms and therapeutic prospects.

Authors:  Elemer Szabadi
Journal:  Br J Clin Pharmacol       Date:  2006-06       Impact factor: 4.335

4.  Inhibition of rat brain lipid synthesis in vitro by 4-hydroxybutyric acid.

Authors:  A R Silva; C Ruschel; C Helegda; A M Brusque; C M Wannmacher; M Wajner; C S Dustra-Filho
Journal:  Metab Brain Dis       Date:  1999-09       Impact factor: 3.584

5.  New synthesis and tritium labeling of a selective ligand for studying high-affinity γ-hydroxybutyrate (GHB) binding sites.

Authors:  Stine B Vogensen; Aleš Marek; Tina Bay; Petrine Wellendorph; Jan Kehler; Christoffer Bundgaard; Bente Frølund; Martin H F Pedersen; Rasmus P Clausen
Journal:  J Med Chem       Date:  2013-10-04       Impact factor: 7.446

Review 6.  Drug treatment of patients with insomnia and excessive daytime sleepiness: pharmacokinetic considerations.

Authors:  S Nishino; E Mignot
Journal:  Clin Pharmacokinet       Date:  1999-10       Impact factor: 6.447

Review 7.  [Gamma-hydroxybutyrate--a neurotransmitter, medicine, and drug].

Authors:  G Trendelenburg; A Ströhle
Journal:  Nervenarzt       Date:  2005-07       Impact factor: 1.214

8.  Pathway-specific action of gamma-hydroxybutyric acid in sensory thalamus and its relevance to absence seizures.

Authors:  Nicolas Gervasi; Zohreh Monnier; Pierre Vincent; Daniele Paupardin-Tritsch; Stuart W Hughes; Vincenzo Crunelli; Nathalie Leresche
Journal:  J Neurosci       Date:  2003-12-10       Impact factor: 6.167

9.  Novel homodimeric and heterodimeric rat gamma-hydroxybutyrate synthases that associate with the Golgi apparatus define a distinct subclass of aldo-keto reductase 7 family proteins.

Authors:  Vincent P Kelly; Philip J Sherratt; Dorothy H Crouch; John D Hayes
Journal:  Biochem J       Date:  2002-09-15       Impact factor: 3.857

10.  Liquid ecstasy - a significant drug problem.

Authors:  Hilke Andresen; Thomas Stimpfl; Nadine Sprys; Tino Schnitgerhans; Alexander Müller
Journal:  Dtsch Arztebl Int       Date:  2008-09-05       Impact factor: 5.594
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.